Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
IDE is a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described but have not been experimentally verified.
Gene Name: | insulin-degrading enzyme |
Family/Subfamily: | Protease , Metallopeptidase M16 |
Synonyms: | IDE, Abeta-degrading protease, Insulinase, INSULYSIN, Insulin protease, Insulin-degrading enzyme |
Target Sequences: | NM_004969 NP_004960.2 P14735 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.